Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Kurbatova EV, et al. Among authors: zignol m. Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43. doi: 10.5588/ijtld.11.0811. Int J Tuberc Lung Dis. 2012. PMID: 23107633
WHO global research priorities for antimicrobial resistance in human health.
Bertagnolio S, Dobreva Z, Centner CM, Olaru ID, Donà D, Burzo S, Huttner BD, Chaillon A, Gebreselassie N, Wi T, Hasso-Agopsowicz M, Allegranzi B, Sati H, Ivanovska V, Kothari KU, Balkhy HH, Cassini A, Hamers RL, Weezenbeek KV; WHO Research Agenda for AMR in Human Health Collaborators. Bertagnolio S, et al. Lancet Microbe. 2024 Nov;5(11):100902. doi: 10.1016/S2666-5247(24)00134-4. Epub 2024 Aug 13. Lancet Microbe. 2024. PMID: 39146948 Free PMC article. Review.
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.
MacLean EL, Miotto P, González Angulo L, Chiacchiaretta M, Walker TM, Casenghi M, Rodrigues C, Rodwell TC, Supply P, André E, Kohli M, Ruhwald M, Cirillo DM, Ismail N, Zignol M. MacLean EL, et al. Among authors: zignol m. PLOS Glob Public Health. 2023 Mar 31;3(3):e0001754. doi: 10.1371/journal.pgph.0001754. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37000774 Free PMC article.
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Deol A, Scarponi D, Iskauskas A, Bakker R, Quaife M, Malhotra S, Gebreselassie N, Zignol M, Hutubessy RCW, Giersing B, Jit M, Harris RC, Menzies NA, White RG. Clark RA, et al. Among authors: zignol m. Lancet Glob Health. 2023 Apr;11(4):e546-e555. doi: 10.1016/S2214-109X(23)00045-1. Lancet Glob Health. 2023. PMID: 36925175 Free PMC article.
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
Portnoy A, Arcand JL, Clark RA, Weerasuriya CK, Mukandavire C, Bakker R, Patouillard E, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA. Portnoy A, et al. Among authors: zignol m. PLoS Med. 2023 Jul 11;20(7):e1004252. doi: 10.1371/journal.pmed.1004252. eCollection 2023 Jul. PLoS Med. 2023. PMID: 37432972 Free PMC article.
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis.
Gupta A, Juneja S, Sahu S, Yassin M, Brigden G, Wandwalo E, Rane S, Mirzayev F, Zignol M. Gupta A, et al. Among authors: zignol m. PLOS Glob Public Health. 2022 Nov 16;2(11):e0001287. doi: 10.1371/journal.pgph.0001287. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962626 Free PMC article. No abstract available.
135 results